| Section 1.31 - Disclosure of confidential cancer information |
|
| Section 2.59 - Prevention of influenza transmission by healthcare and residential facility and agency personnel |
|
| Section 12.3 - Precautions to be observed for the prevention of hemorrhagic diseases and coagulation disorders of the newborn and infants related to vitamin K deficiency |
|
| Section 400.14 - Request for patient review instrument (PRI) data |
|
| Section 400.21 - Advance directives |
|
| Section 405.13 - Anesthesia services |
|
| Section 405.30 - Organ and Vascularized Composite Allograft Transplant Services/Programs |
|
| Section 405.43 REPEALED |
|